KZR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Kezar Life Sciences Inc (KZR) is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. The lack of significant trading signals, neutral trading trends, weak financial performance, and no recent positive news or catalysts make this stock less appealing for immediate investment. Holding or exploring other opportunities may be more prudent.
The technical indicators show mixed signals. While the moving averages are bullish (SMA_5 > SMA_20 > SMA_200), the MACD is negative and expanding downward (-0.0276), and the RSI is neutral at 43.424. The stock is trading near its pivot level of 7.352, with support at 7.238 and resistance at 7.467. Overall, no clear bullish momentum is observed.
NULL identified. No recent news, no significant insider or hedge fund activity, and no congress trading data available.
Weak financial performance in Q4 2025, with a 28.05% YoY drop in net income and a 28.16% YoY drop in EPS. No recent trading signals or positive sentiment from institutional or insider trading.
In Q4 2025, revenue remained at 0 with no growth. Net income declined by 28.05% YoY to -$14,546,000, and EPS dropped by 28.16% YoY to -1.99. Gross margin remained at 0, showing no improvement.
No recent analyst ratings or price target updates are available for KZR.
